Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thanks a lot for your information
Whenever I try to enter, there is news that coming out. When is the next news ? 15 Sept?
wise decision
I am interested in CPRX. In your opinion, what would be the entry point?
I'm new with CUR and I would need to know if there is reason to worry about this news:
StemCells Inc. Patent Infringement and Libel Suits Against Neuralstem (Amex:CUR)
In July 2006, StemCells Inc. filed suit against Neuralstem, Inc. in the Federal District Court for the District of Maryland,
alleging that Neuralstem’s activities violate claims in four of the patents exclusively licensed from NeuroSpheres,
specifically U.S. Patent No. 6,294,346 (claiming the use of human neural stem cells for drug screening), U.S. Patent No.
7,101,709 (claiming the use of human neural stem cells for screening biological agents), U.S. Patent No. 5,851,832
(claiming methods for proliferating human neural stem cells), and U.S. Patent No. 6,497,872 (claiming methods for
transplanting human neural stem cells).
In May 2008, StemCells Inc. filed a second patent infringement suit against Neuralstem and its two founders, Karl Johe
and Richard Garr. In this suit, filed in the Federal District Court for the Northern District of California, they allege that
Neuralstem’s activities infringe claims in two patents exclusively license from NeuroSpheres, specifically U.S. Patent No.
7,361,505 (claiming composition of matter of human neural stem cells derived from any source material) and U.S. Patent
No. 7,115,418 (claiming methods for proliferating human neural stem cells). In addition, they allege various state law
causes of action against Neuralstem arising out of its repeated derogatory statements to the public about their patent
portfolio. Also in May 2008, Neuralstem filed suit against StemCells Inc. and NeuroSpheres in the Federal District Court
for the District of Maryland seeking a declaratory judgment that the ‘505 and ‘418 patents are either invalid or are not
infringed by Neuralstem and that Neuralstem has not violated California state law. In August 2008, the California court
transferred the lawsuit against Neuralstem to Maryland for resolution on the merits. In July 2009, the Maryland District
Court granted SremCells Inc.’s motion to consolidate these two cases with the litigation they initiated against Neuralstem
in 2006. Discovery is ongoing in these cases with an anticipated trial date in 2014.
ref:http://lifetechcapital.com/ltc/wp-content/uploads/2013/08/STEM-Update-08-22-13.pdf
Commented on: "Patience Required For Dara Bio Investment"
http://seekingalpha.com/article/1638362-patience-required-for-dara-bio-investment?source=kizur
I sold all my shares this morning with 50% loss. It's horrible but I'll sleep better now. For the moment, the risk/reward is too risky (IMO). The ODD still in play, but chance are slim according Jason.
From Twitter :
Jason Napodano, CFA ?@JNapodano (11 June)
(Gotta believe that $DARA's chances of ODS on KRN5500 are slim based on this >>http://www.raps.org/focus-online/news/news-article-view/article/3608/fda-finalizes-changes-to-orphan-drug-regulation-with-emphasis-on-clarifying-exi.aspx)
Here is a cut & paste from twitter:
@tassitano: @JNapodano Quick question. Is there a reason to worry? is it a dilution?
2013-08-19 19:32
@JNapodano: @tassitano I figured they needed cash at some point. This is only about 1/2 of what I think they need. Less painful than a big hit.
2013-08-19 20:01
Sorry, here is the fact. I spoke to Jason yesterday and nothing about ODD status. He tell me that "they need cash at some point. This is only about 1/2 of what I think they need. Less painful than a big hit."
$2.73 million ATM? On twitter, they said that the ODD has been denied and Dara need money to survive.
Yes they provided more information and I really hope it will be enough to convince the FDA. The deadline for compliance is Nov. but I know that they can request an extension of 180 days.
I thought making money with this stock but now I just want to avoid big losses
I think the chances of rejection (ODD) are high because the chronic neuropathic pain in cancer patient market is clearly larger than 200,000. According Jason Napodano, "a deal is contingent upon ODD. With ODD + partner, $1.50 doable". I'm wondering if investors will take the chance. What do you think?
Are you disappointed? Do you intend to sell before September?
According Jason Napodano:
Revs: $77K vs. $50K est.
NI: -$2.55M vs. $2.51M est.
EPS: -10c. SO: 25.001M.
Cash: $4.94M (6.3 Mos at current burn from June 30th)
dates to watch:
1) Mid-to-late Sept for FDA response on ODD for KRN5500
2) Nov 11th to regain compliance with NASDAQ min-$1 bid.
Dara Biosciences, Inc Files 8-K : Results of Operations and Financial Condition, Financial Statements and Exhibits, ...
http://boardvote.com/symbol/DARA/communique/418679
I really hope so! this situation makes me nervous.
Question for all :
1 - Do you plan to sell Dara before the next earning?
2 - Do you think that Dara will be able to respect the nasdaq's compliance before november ?
Some people say that Dara would have received a response from the FDA. I'm wondering if they will wait for the next earning to give the news. According Nasdaq, the next earning is Aug 21, 2013 (http://www.nasdaq.com/earnings/report/dara).
I'm exactly in the same situation. I had the opportunity to sell in 2013, but I took the chance to stay.
Just curious, you own Dara since when?
Any chance to have a response from the FDA in July?
Everyday, Dara bleeds a little more. I'm wondering when the mgmt team will wake up and give news to investors.
Have you obtained news from Dara? The latest news that we have is dated 14 June.
From my side, i'm in pending mode and planned to buy more when a big news will coming out. Thanks to share your point of view.
Pretty good question.
I'm in the same boat. However, the idea of ??a reverse split scares me ... every day, Dara hit a new low level... they will probably wait for the next earning before giving news (Aug 14, 2013).
Silence on the board...Have you sold all your shares?
Not much has changed for DARA. i.e. still looking for partner, commercializing drugs. http://www.twitlonger.com/show/n_1rkqnp7
I'd like to believe but Dara seems rejected by investors. No news from the FDA or investors...each day is a new bottom. IMO, we need something very big to reverse this trend. Do you think DARA will comply with Nasdaq rules before the deadline? This is my bigger concern.
DARA Biosciences just filed its Current report, items 8.01 and 9.01
http://www.sec.gov/Archives/edgar/data/919745/000135448813003515/0001354488-13-003515-index.htm
DARA BioSciences Grants T3D Therapeutics Exclusive Worldwide Rights to Develop and Commercialize DB959
http://boardvote.com/symbol/DARA/communique/369661
Thank you for your information :)
So, what is your opinion on Dara ?
yes, but do you think it could reach $1 soon?
Jason Napodano :
"Jury is still out. I was too eager on the ODD filing and sales trajectory remains a question market. Stock is cheap though."
Jason Napodano says "Gotta believe that DARA's chances of ODS on KRN5500 are slim based on this" (New FDA rules)
I wonder what is the strategy. The price of the stock does not seem to be influenced.
FORM4 : DARA Biosciences just filed its Statement of changes in beneficial ownership of securities
Another buy today...I hope this attempt is symbolic.